Horizons International Corp.
HIC is a World Wide medical device company that brings to the market innovative products to better detect diseases such as cancer through minimally invasive procedures. We design, develop, manufacture, sterilize, commercialize and distribute products and services that target diseases in the lungs and gastrointestinal digestive organs.
Conditions our devices help identify are:
- Gastrointestinal Cancer
- Lung Cancer
- Pulmonary Diseases
- Malignant Tumors in stomach, colon and lungs
- Benign tumors
- Among others
HIC has dedicated itself to designing instruments that are not only minimally invasive, but assure the samples and biopsies captured are retrieved in one single pass.
This delivers an assurance that the patients samples will not be lost and proper diagnostic can be achieved. “A lost sample/biopsy is a lost opportunity for an accurate and timely diagnosis”. “Which could represent a saved life!”
HIC is privately held. Establish in 1994, Manufacturing Facilities are in Heredia, Costa Rica.
CEO Rafic Saleh
Mission
We strive to continually improve the quality of our products and the speed and efficiency with which we respond to help diagnose patients around the world.
Vision:
“Be a Worldwide Leader in the field of Gastroenterology and Pulmonary ”
Values:
We have a Commitment to:
- Partnership “ Distributors, Employees, Suppliers”
- Focus “HIC is customer oriented.” This leads us to new products, continuous learning and innovation.
- Accountability “To sustain a competitive advantage in the market place it is key to build a track record of reaching or exceeding business objectives.”
Message from Rafic Saleh
President of Horizons International Corp
Though we are all living in the most challenging of moments, I am hopeful about our journey at Horizons’, standing on our pillars of listening, innovating and creating to save lives. As we have all been reading, secondary diseases from COVID-19 affect not only the pulmonary system but the gastrointestinal organs amongst others. Staying true to our ever-present commitment to help save lives, has us at HIC, thinking what can we uniquely contribute to COVID-19, in a simple and easily accessible manner? As with other moments in our history, when we set our eyes on the target, we raise ourselves to contribute to the challenges we are facing. This time together as a world in need of innovation, compassion and solidarity. We are extremely passionate about the contributions our team makes and the knowledge HIC has acquired throughout the past two decades on behalf of innovation and science. HIC has made the decision to venture and invest in COVID-19 solutions with our pillars in our forefront. Aiming now more than ever to listen, innovate and create to save lives.
As we make progress, I will be updating this message. Be safe,
Rafic Saleh
President